Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Historical Holders from Q1 2016 to Q4 2024

Symbol
ADVM on Nasdaq
CUSIP
00773U108
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
20.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
507K
Holdings value
$2.37M
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 11.4% $10.6M 2.37M Leonard Braden Michael Dec 31, 2024

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 507K $2.37M $4.67 1
2024 Q3 507K $3.56M -$13.8M $7.02 1
2024 Q2 2.52M $17.3M -$15.1M $6.86 2
2024 Q1 3.58M $50.7M -$61.4M $14.14 3
2023 Q4 64M $48.1M +$29.2M $0.75 58
2023 Q3 9.26M $13.9M -$57.2K $1.50 8
2023 Q2 65.5M $104M +$5.75M $1.59 56
2023 Q1 61.3M $44M +$4.08M $0.72 53
2022 Q4 57.1M $33.1M -$6.72M $0.58 56
2022 Q3 58.5M $55.6M -$1.21M $0.95 71
2022 Q2 57.9M $69.5M -$6.74M $1.20 65
2022 Q1 62.1M $81.4M -$1.33M $1.31 80
2021 Q4 65.6M $115M -$8.01M $1.76 93
2021 Q3 60.7M $132M -$22.9M $2.17 104
2021 Q2 76.4M $267M -$216M $3.50 112
2021 Q1 95.1M $938M +$10.3M $9.86 130
2020 Q4 91.7M $994M -$15.9M $10.84 149
2020 Q3 95M $979M +$112M $10.30 155
2020 Q2 80.9M $1.69B +$34.6M $20.88 138
2020 Q1 79.8M $780M +$235M $9.77 122
2019 Q4 56.1M $646M +$34.2M $11.52 113
2019 Q3 48.8M $266M -$13.1M $5.45 96
2019 Q2 46.3M $549M +$95.4M $11.89 92
2019 Q1 39.7M $208M +$8.79M $5.24 82
2018 Q4 38.2M $120M -$9.94M $3.15 81
2018 Q3 34.5M $209M -$12.8M $6.05 101
2018 Q2 36.7M $194M +$9.8M $5.30 99
2018 Q1 34.6M $201M +$91.8M $5.80 95
2017 Q4 19.2M $67.3M +$19.6M $3.50 63
2017 Q3 13.6M $49.5M +$3.29M $3.65 55
2017 Q2 13M $32.5M -$1.44M $2.50 59
2017 Q1 13.5M $36.5M +$2.26M $2.70 70
2016 Q4 15.1M $43.8M -$555K $2.90 78
2016 Q3 15.3M $62.7M -$937K $4.11 73
2016 Q2 15.8M $49.8M +$49.1M $3.16 74
2016 Q1 226K $1.17M +$1.14M $5.17 3